IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia	Hemic and Lymphatic Diseases, hematologic disorder, neoplasm	Recruiting	Phase 1	2025-12-10		NCT07257640

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The first affiliated hospital of medical college of zhejiang university	Hangzhou	China	13

Clinical trials